Business ❯ Healthcare ❯ Pharmaceutical Industry

Drug Development

Clinical Trials Market Dynamics Investor Relations Cancer Medications Pfizer Products Innovative Therapies Antibodies Transparency in Drug Approval Obesity Treatments Biosimilars GLP-1 Drugs Weight-Loss Treatments Market Competition GLP-1 Medicines Clinical Research Precision Medicine Oncology Pipeline Patent Expiration Peptide Drugs Women's Health GLP-1 Weight-Loss Drugs Oncology Treatments Generic Drugs Therapeutic Innovations

Wall Street Unanimously Bullish on Teva as Austedo Fuels Turnaround

Analysts say rising Austedo sales alongside Teva's move into branded drugs could lift the stock if the company sustains execution.

Lilly’s Foundayo Start Trails Wegovy as Street Stays Positive

Ligand to Buy XOMA Royalty for $739 Million

Eli Lilly’s Q4 Beat and Bullish Outlook Give Way to Stock Drop on Low-Cost GLP-1 Pills

AbbVie Beats Q4 and Raises 2026 Outlook as Shares Fall on Aesthetics, Oncology Concerns

Eli Lilly Becomes First Health Care Company Valued at $1 Trillion

AI Pinpoints Target of New IBD Antibiotic Enterololin, Speeding Development

Berenberg Upgrades Novo Nordisk to Buy, Sets DKK425 Price Target

FDA Publishes Over 200 Complete Response Letters for 2020–24 Drug Applications

Merck to Acquire Verona Pharma in $10 Billion Deal for Ohtuvayre COPD Therapy